{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:08:43Z","timestamp":1791410923711,"version":"4.3.3"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Recent studies have shown gender differences in cardiovascular outcomes after left atrial appendage closure (LAAC), highlighting different complication rates and adverse events, particularly in short-term assessments. As a result, there remains a significant knowledge gap on how these differences directly impact the efficacy and safety of LAAC procedures. The aim of this retrospective study was to investigate the clinical outcomes of LAAC in women and men using the Watchman FLX device.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective, multicenter study analyzes gender-specific outcomes in 650 patients who underwent LAAC with the Watchman FLX device between March 2019 and May 2022, drawn from the ITALIAN-FLX registry.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The results show comparable rates of all-cause mortality, stroke, transient ischemic attack and major bleeding in men and women 12 months after the procedure. Notably, no significant gender differences were found for periprocedural complications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In conclusion, this study shows that LAAC with the Watchman FLX device has comparable clinical outcomes between genders at both short-term and long-term follow-up.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2024.1419018","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T04:58:22Z","timestamp":1721883502000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Gender differences in outcomes after left atrial appendage closure with Watchman FLX device: insights from the Italian-FLX registry"],"prefix":"10.3389","volume":"11","author":[{"given":"Michela","family":"Bonanni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Frazzetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Nardone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Meucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Musto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Quaranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Sacc\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bedogni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Maffeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Ugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Guarracini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Bocuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Durante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Granatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Tumminello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geppina","family":"Eusebio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Grasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"De Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Cortese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Berti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.112.114389","article-title":"Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman left atrial appendage system for embolic protection in patients with atrial fibrillation) trial","volume":"127","author":"Reddy","year":"2013","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","article-title":"4-Year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation","volume":"79","author":"Osmancik","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.cjca.2021.02.005","article-title":"The importance of gender to understand sex differences in cardiovascular disease","volume":"37","author":"Connelly","year":"2021","journal-title":"Can J Cardiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/2047487312460519","article-title":"Gender difference in long-term prognosis among patients with cardiovascular disease","volume":"21","author":"van der Meer","year":"2014","journal-title":"Eur J Prev Cardiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1001\/jamacardio.2021.3021","article-title":"Sex differences in procedural outcomes among patients undergoing left atrial appendage occlusion: insights from the NCDR LAAO registry","volume":"6","author":"Darden","year":"2021","journal-title":"JAMA Cardiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/j.mayocp.2020.11.031","article-title":"Sex differences in outcomes following left atrial appendage closure","volume":"96","author":"Sanjoy","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.121.057063","article-title":"Amplatzer amulet left atrial appendage occluder versus watchman device for stroke prophylaxis (amulet IDE): a randomized, controlled trial","volume":"144","author":"Lakkireddy","year":"2021","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1016\/j.jcin.2022.06.037","article-title":"Sex differences in safety and effectiveness of LAAO: insights from the amulet IDE trial","volume":"15","author":"Alkhouli","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.120.050117","article-title":"Primary outcome evaluation of a next-generation left atrial appendage closure device","volume":"143","author":"Kar","year":"2021","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/ccd.30237","article-title":"Real-world experience with the new watchman FLX device: data from two high-volume Sicilian centers. The FLX-iEST registry","volume":"100","author":"Vizzari","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1115811","DOI":"10.3389\/fcvm.2023.1115811","article-title":"Periprocedural outcome in patients undergoing left atrial appendage occlusion with the watchman FLX device: the ITALIAN-FLX registry","volume":"10","author":"Berti","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jacc.2015.05.049","article-title":"Mitral valve academic research consortium (MVARC). Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: a consensus document from the mitral valve academic research consortium","volume":"66","author":"Stone","year":"2015","journal-title":"J. Am. Coll. Cardiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/europace\/euw141","article-title":"Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies","volume":"19","author":"Tzikas","year":"2017","journal-title":"Europace"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/ccd.29282","article-title":"Sex-stratified analysis of the safety of percutaneous left atrial appendage occlusion","volume":"97","author":"Osman","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1111\/jce.15189","article-title":"Interventional occlusion of left atrial appendage in patients with atrial fibrillation. Gender- related outcomes in the German LAARGE registry","volume":"32","author":"Kleinecke","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/ccd.30323","article-title":"Sex differences on outcomes following left atrial appendage occlusion in atrial fibrillation: a systematic review and meta-analysis","volume":"100","author":"Zhu","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"key":"B19","doi-asserted-by":"publisher","first-page":"100848","DOI":"10.1016\/j.ijcha.2021.100848","article-title":"Gender difference in left atrial appendage occlusion outcomes: results from the amplatzer amulet observational study","volume":"35","author":"De Caterina","year":"2021","journal-title":"Int J Cardiol Heart Vasc"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.7150\/ijms.53221","article-title":"Impact of sex differences on outcomes in patients with non-valvular atrial fibrillation undergoing left atrial appendage closure: a single-center experience","volume":"18","author":"Zhao","year":"2021","journal-title":"Int J Med Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"814958","DOI":"10.3389\/fcvm.2022.814958","article-title":"Sex differences in efficacy and safety after left atrial appendage closure: a 4.3-year follow-up analysis","volume":"9","author":"Chen","year":"2022","journal-title":"Front Cardiovasc Med"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1419018\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T15:13:09Z","timestamp":1722352389000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1419018\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":21,"alternative-id":["10.3389\/fcvm.2024.1419018"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1419018","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,25]]},"article-number":"1419018"}}